Antiviral clinical trials taking place in Cleveland
By: Sylvia Rose
Posted: Mar 21, 2020 10:48 PM EST

-
1:44
Ice Pillars explained
-
2:44
New beginnings at The Bend Lounge, a place for community, creativity...
-
2:03
System and lake effect snow tonight leads to travel concerns...
-
2:38
Benton Harbor Commissioners vote to increase city’s garbage...
-
2:47
Future of County-City building still up in the air as more look...
-
3:16
Lacasa partners with Oaklawn to support unhoused seniors
-
1:22
More snow and bitter cold, heavier snow by Thursday morning
-
3:24
Cummings out, South Bend school board to name interim superintendent
-
4:42
Mayor Mueller discusses upcoming investments for the city of...
-
1:48
Scattered lake effect snow, widespread cold today
-
2:23
Barrier breaking legacy of Elkhart family stretches back decades
-
3:00
Billboards pop up across South Bend honoring local Black leaders
CLEVELAND, Ohio – University Hospitals in Cleveland are taking the next step in fighting COVID-19, securing two clinical trials that will provide an antiviral drug to adults who have been hospitalized with pneumonia due to the virus.
Leaders of the study are hoping to test around 1000 people nationwide.
"Because there's no other treatment now so it's really exciting to see a drug that could hit the virus itself, not just supportive care," said Dr. Grace McComsey, a doctor at University Hospitals.
The trial should provide information on whether the drug can help lower fevers and normalize oxygen saturation in patients.
The drug is federally regulated and was safely tested on more than 500 people during the Ebola outbreak.
Sign up for the ABC 57Newsletter